Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Christine Garnett, Subha Madhavan

Premium

Certara has hired Christine Garnett to serve as a principal scientist.

In her role, Garnett will lead efforts to develop cardiac safety modeling tools on the company’s Phoenix software platform and she will also work closely with Pharsight's global consulting services team on predictive modeling engagements that leverage early clinical study data to assess the cardiac proarrhythmic risk of new drug candidates.

Garnett has more than 15 years of experience in clinical pharmacology and cardiovascular safety, including exposure-response modeling for regulatory decisions, population pharmacokinetic analysis, and evaluation of concentration-QTc data for optimal trial design and dose selection.

Prior to joining Certara, she served as team leader in the US Food and Drug Administration’s division of pharmacometrics and as the scientific leader of the FDA's interdisciplinary review team for QT studies. She has also led pharmacometrics teams in multiple therapeutic areas such as oncology, metabolism, and gastroenterology.


Georgetown University Medical Center has tapped Subha Madhavan to serve as the inaugural director of its newly launched Innovation Center for Biomedical Informatics.

Madhavan is the director of clinical research informatics at GU’s Lombardi comprehensive cancer center. Prior to joining the university, she was the associate director of product and program management for life science informatics at the National Cancer Institute’s Center for Biomedical Informatics and Information technology.

She holds a doctorate in molecular biology from the Uniformed Services University for Health Sciences and a master's degree in computer information systems from the University of Maryland.


The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.